Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Hsiao-Nakamoto J"'
Autor:
Vissers, M.F.J.M., Heuberger, J.A.A.C., Groeneveld, G.J., Nijhuis, J.O., Deyn, P.P. de, Hadi, S., Harris, J., Tsai, R.M., Cruz-Herranz, A., Huang, F., Tong, V., Erickson, R., Zhu, Y.D., Scearce-Levie, K., Hsiao-Nakamoto, J., Tang, X.Y., Chang, M., Fox, B.M., Pomponio, R.J., Alonso-Alonso, M., Zilberstein, M., Atassi, N., Troyer, M.D., Ho, C.
Publikováno v:
Clinical and translational science, 15(8), 2010-2023. Wiley
Clinical and Translational Science, 15(8), 2010-2023. WILEY
Clinical and translational science
Clinical and Translational Science, 15(8), 2010-2023. WILEY
Clinical and translational science
RIPK1 is a master regulator of inflammatory signaling and cell death and increased RIPK1 activity is observed in human diseases, including Alzheimer's disease (AD) and amyotrophic lateral sclerosis (ALS). RIPK1 inhibition has been shown to protect ag
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::af01500ec9f2208e7f2c9d74b053cf6c
https://research.rug.nl/en/publications/68746f94-9889-48a0-8f8d-428a9c348bbf
https://research.rug.nl/en/publications/68746f94-9889-48a0-8f8d-428a9c348bbf
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Guo JL; Denali Therapeutics Inc., South San Francisco, CA, USA. Electronic address: guojing84@hotmail.com., Braun D; Denali Therapeutics Inc., South San Francisco, CA, USA., Fitzgerald GA; Denali Therapeutics Inc., South San Francisco, CA, USA., Hsieh YT; Denali Therapeutics Inc., South San Francisco, CA, USA., Rougé L; Denali Therapeutics Inc., South San Francisco, CA, USA., Litvinchuk A; Department of Neurology, Washington University School of Medicine, St. Louis, MO, USA., Steffek M; Denali Therapeutics Inc., South San Francisco, CA, USA., Propson NE; Denali Therapeutics Inc., South San Francisco, CA, USA., Heffner CM; Denali Therapeutics Inc., South San Francisco, CA, USA., Discenza C; Denali Therapeutics Inc., South San Francisco, CA, USA., Han SJ; Denali Therapeutics Inc., South San Francisco, CA, USA., Rana A; Denali Therapeutics Inc., South San Francisco, CA, USA., Skuja LL; Denali Therapeutics Inc., South San Francisco, CA, USA., Lin BQ; Denali Therapeutics Inc., South San Francisco, CA, USA., Sun EW; Denali Therapeutics Inc., South San Francisco, CA, USA., Davis SS; Denali Therapeutics Inc., South San Francisco, CA, USA., Balasundar S; Denali Therapeutics Inc., South San Francisco, CA, USA., Becerra I; Denali Therapeutics Inc., South San Francisco, CA, USA., Dugas JC; Denali Therapeutics Inc., South San Francisco, CA, USA., Ha C; Denali Therapeutics Inc., South San Francisco, CA, USA., Hsiao-Nakamoto J; Denali Therapeutics Inc., South San Francisco, CA, USA., Huang F; Denali Therapeutics Inc., South San Francisco, CA, USA., Jain S; Denali Therapeutics Inc., South San Francisco, CA, USA., Kung JE; Denali Therapeutics Inc., South San Francisco, CA, USA., Liau NPD; Denali Therapeutics Inc., South San Francisco, CA, USA., Mahon CS; Denali Therapeutics Inc., South San Francisco, CA, USA., Nguyen HN; Denali Therapeutics Inc., South San Francisco, CA, USA., Nguyen N; Denali Therapeutics Inc., South San Francisco, CA, USA., Samaddar M; Denali Therapeutics Inc., South San Francisco, CA, USA., Shi Y; Denali Therapeutics Inc., South San Francisco, CA, USA., Tatarakis D; Denali Therapeutics Inc., South San Francisco, CA, USA., Tian Y; Denali Therapeutics Inc., South San Francisco, CA, USA., Zhu Y; Denali Therapeutics Inc., South San Francisco, CA, USA., Suh JH; Denali Therapeutics Inc., South San Francisco, CA, USA., Sandmann T; Denali Therapeutics Inc., South San Francisco, CA, USA., Calvert MEK; Denali Therapeutics Inc., South San Francisco, CA, USA., Arguello A; Denali Therapeutics Inc., South San Francisco, CA, USA., Kane LA; Denali Therapeutics Inc., South San Francisco, CA, USA., Lewcock JW; Denali Therapeutics Inc., South San Francisco, CA, USA., Holtzman DM; Department of Neurology, Washington University School of Medicine, St. Louis, MO, USA., Koth CM; Denali Therapeutics Inc., South San Francisco, CA, USA., Di Paolo G; Denali Therapeutics Inc., South San Francisco, CA, USA. Electronic address: dipaolo@dnli.com.
Publikováno v:
Cell [Cell] 2024 Nov 11. Date of Electronic Publication: 2024 Nov 11.
Autor:
Logan T, Simon MJ, Rana A, Cherf GM, Srivastava A, Davis SS, Yoon Low RL, Chiu CL, Fang M, Huang F, Bhalla A, Llapashtica C, Prorok R, Pizzo ME, Calvert MEK, Sun EW, Hsiao-Nakamoto J, Rajendra Y, Lexa KW, Srivastava DB, van Lengerich B, Wang J, Robles-Colmenares Y, Kim DJ, Duque J, Lenser M, Earr TK, Nguyen H, Chau R, Tsogtbaatar B, Ravi R, Skuja LL, Solanoy H, Rosen HJ, Boeve BF, Boxer AL, Heuer HW, Dennis MS, Kariolis MS, Monroe KM, Przybyla L, Sanchez PE, Meisner R, Diaz D, Henne KR, Watts RJ, Henry AG, Gunasekaran K, Astarita G, Suh JH, Lewcock JW, DeVos SL, Di Paolo G
Publikováno v:
Cell [Cell] 2024 Mar 14; Vol. 187 (6), pp. 1565-1566.
Autor:
Hsiao-Nakamoto J; Denali Therapeutics Inc., 161 Oyster Point, South San Francisco, CA, 94080, USA.; These authors contributed equally., Chiu CL; Denali Therapeutics Inc., 161 Oyster Point, South San Francisco, CA, 94080, USA.; These authors contributed equally., VandeVrede L; Department of Neurology, Memory and Aging Center, University of California San Francisco, San Francisco, CA, 94158, USA., Ravi R; Denali Therapeutics Inc., 161 Oyster Point, South San Francisco, CA, 94080, USA., Vandenberg B; Denali Therapeutics Inc., 161 Oyster Point, South San Francisco, CA, 94080, USA.; Present address: Brittany Vandenberg, Washington State University, Pullman, WA 99164, USA., De Groot J; Denali Therapeutics Inc., 161 Oyster Point, South San Francisco, CA, 94080, USA.; Present address: Jack DeGroot: Prime Medicine Inc., Cambridge, MA 02139, USA., Tsogtbaatar B; Denali Therapeutics Inc., 161 Oyster Point, South San Francisco, CA, 94080, USA., Fang M; Denali Therapeutics Inc., 161 Oyster Point, South San Francisco, CA, 94080, USA., Auger P; Denali Therapeutics Inc., 161 Oyster Point, South San Francisco, CA, 94080, USA.; Present address: Paul Auger: Nurix Therapeutics, San Francisco, CA 94158, USA., Gould NS; Denali Therapeutics Inc., 161 Oyster Point, South San Francisco, CA, 94080, USA., Marchioni F; Denali Therapeutics Inc., 161 Oyster Point, South San Francisco, CA, 94080, USA., Powers CA; Denali Therapeutics Inc., 161 Oyster Point, South San Francisco, CA, 94080, USA.; Present address: Casey A. Powers: Stanford University, Stanford, CA 94305, USA., Davis SS; Denali Therapeutics Inc., 161 Oyster Point, South San Francisco, CA, 94080, USA., Suh JH; Denali Therapeutics Inc., 161 Oyster Point, South San Francisco, CA, 94080, USA., Alkabsh J; Denali Therapeutics Inc., 161 Oyster Point, South San Francisco, CA, 94080, USA., Heuer HW; Department of Neurology, Memory and Aging Center, University of California San Francisco, San Francisco, CA, 94158, USA., Lago AL; Department of Neurology, Memory and Aging Center, University of California San Francisco, San Francisco, CA, 94158, USA., Scearce-Levie K; Denali Therapeutics Inc., 161 Oyster Point, South San Francisco, CA, 94080, USA.; Present address: Kimberly Scearce-Levie: Cajal Neuroscience, Seattle, WA 98109, USA., Seeley WW; Department of Neurology, Memory and Aging Center, University of California San Francisco, San Francisco, CA, 94158, USA., Boeve BF; Department of Neurology, Mayo Clinic, Rochester, MN 55905, USA., Rosen HJ; Department of Neurology, Memory and Aging Center, University of California San Francisco, San Francisco, CA, 94158, USA., Berger A; Denali Therapeutics Inc., 161 Oyster Point, South San Francisco, CA, 94080, USA., Tsai R; Denali Therapeutics Inc., 161 Oyster Point, South San Francisco, CA, 94080, USA., Di Paolo G; Denali Therapeutics Inc., 161 Oyster Point, South San Francisco, CA, 94080, USA., Boxer AL; Department of Neurology, Memory and Aging Center, University of California San Francisco, San Francisco, CA, 94158, USA.; These authors contributed equally., Bhalla A; Denali Therapeutics Inc., 161 Oyster Point, South San Francisco, CA, 94080, USA.; These authors contributed equally., Huang F; Denali Therapeutics Inc., 161 Oyster Point, South San Francisco, CA, 94080, USA.; These authors contributed equally.
Publikováno v:
BioRxiv : the preprint server for biology [bioRxiv] 2024 Feb 12. Date of Electronic Publication: 2024 Feb 12.
Autor:
Vissers MFJM; Centre for Human Drug Research, Leiden, The Netherlands.; Leiden University Medical Center, Leiden, The Netherlands., Heuberger JAAC; Centre for Human Drug Research, Leiden, The Netherlands., Groeneveld GJ; Centre for Human Drug Research, Leiden, The Netherlands.; Leiden University Medical Center, Leiden, The Netherlands., Oude Nijhuis J; Department of Neurology and Alzheimer Center, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands., De Deyn PP; Department of Neurology and Alzheimer Center, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.; Laboratory of Neurochemistry and Behavior, Department of Biomedical Sciences and Institute Born-Bunge, University of Antwerp, Antwerp, Belgium., Hadi S; PRA Health Sciences, Groningen, The Netherlands., Harris J; Denali Therapeutics Inc., South San Francisco, California, USA., Tsai RM; Denali Therapeutics Inc., South San Francisco, California, USA., Cruz-Herranz A; Denali Therapeutics Inc., South San Francisco, California, USA., Huang F; Denali Therapeutics Inc., South San Francisco, California, USA., Tong V; Denali Therapeutics Inc., South San Francisco, California, USA., Erickson R; Denali Therapeutics Inc., South San Francisco, California, USA., Zhu Y; Denali Therapeutics Inc., South San Francisco, California, USA., Scearce-Levie K; Denali Therapeutics Inc., South San Francisco, California, USA., Hsiao-Nakamoto J; Denali Therapeutics Inc., South San Francisco, California, USA., Tang X; Denali Therapeutics Inc., South San Francisco, California, USA., Chang M; Denali Therapeutics Inc., South San Francisco, California, USA., Fox BM; Denali Therapeutics Inc., South San Francisco, California, USA., Estrada AA; Denali Therapeutics Inc., South San Francisco, California, USA., Pomponio RJ; Sanofi Genzyme, Cambridge, Massachusetts, USA., Alonso-Alonso M; Sanofi Genzyme, Cambridge, Massachusetts, USA., Zilberstein M; Sanofi Genzyme, Cambridge, Massachusetts, USA., Atassi N; Sanofi Genzyme, Cambridge, Massachusetts, USA., Troyer MD; Denali Therapeutics Inc., South San Francisco, California, USA., Ho C; Denali Therapeutics Inc., South San Francisco, California, USA.
Publikováno v:
Clinical and translational science [Clin Transl Sci] 2022 Aug; Vol. 15 (8), pp. 2010-2023. Date of Electronic Publication: 2022 Jun 01.